Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia.

Virology Journal
M MendyH Whittle

Abstract

Little is known about changes in hepatitis B viral load (HBV DNA) in relation to age in Africa. The aim of this study is to determine the natural course of HBV chronic infection, particularly in relation to sequential changes in serum HBV DNA levels and hepatitis B surface (HBsAg) antigen/hepatitis e antigen (HBeAg) status by age. The study was conducted on 190 HBV chronic carriers, aged 1-19 years who were followed for 19 years. 160, 99 and 123 were traced at 5, 9 and 19 years later. All available samples were tested for HBsAg and HBeAg, whilst 170, 61, 63 and 81 were tested for HBV DNA at the baseline, and at 5, 9 and 19 years following recruitment. In general HBeAg which correlated with high levels of HBV DNA was lost at a much faster rate than HBsAg. 86% of the carriers who were recruited at the age of 1-4 yrs lost HBeAg by the age of 19 years compared to 30% who lost HBsAg. HBeAg negative carriers had serum HBV DNA levels of < 105 copies per mL, HBV DNA positivity declined from 100% in 1-4 yrs old carriers at recruitment to 62.5%,60% and 88% at 5, 9 and 19 years respectively following recruitment. After 19 years of follow up, the majority of HBV surface antigen carriers had lost HBeAg positivity and had low levels of viral...Continue Reading

References

Jun 1, 1990·The Journal of Infectious Diseases·H WhittleA J Hall
May 28, 1983·Lancet·H C WhittleI A McGregor
Sep 24, 1983·Lancet·H C WhittleI A McGregor
Dec 11, 1997·The New England Journal of Medicine·W M Lee
Jan 20, 2000·Journal of the National Cancer Institute·G D KirkR Montesano
Aug 2, 2000·Journal of Gastroenterology and Hepatology·C J ChenM W Yu
May 5, 2001·British Journal of Cancer·E BahH Whittle
Dec 18, 2001·Journal of Medical Virology·U DumpisP Karayiannis
Jul 19, 2002·The New England Journal of Medicine·Hwai-I YangUNKNOWN Taiwan Community-Based Cancer Screening Project Group
Nov 22, 2002·The New England Journal of Medicine·Andreas GeierChristoph G Dietrich
Jan 31, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gregory D KirkRuggero Montesano
Jun 9, 2004·Annals of Medicine·San-Lin YouChien-Jen Chen
Mar 1, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gregory D KirkChristopher P Wild
Jan 5, 2006·JAMA : the Journal of the American Medical Association·Chien-Jen ChenUNKNOWN REVEAL-HBV Study Group
Feb 8, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Delphine CougotMarie Annick Buendia
May 3, 2006·The Journal of Infectious Diseases·M A B van der SandeH C Whittle
May 5, 2006·Seminars in Liver Disease·Chee-Kin Hui, George K K Lau
Jul 14, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chee-Kin HuiUNKNOWN Hong Kong Liver Fibrosis Study Group

❮ Previous
Next ❯

Citations

Sep 17, 2010·Virology Journal·Modou JobartehMaimuna Mendy
Mar 3, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Yusuke ShimakawaAndrew J Hall
Oct 21, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Latifa T F Yeung, Eve A Roberts
Nov 1, 2017·Scientific Reports·Jasmine SamalPerumal Vivekanandan
Jun 6, 2018·The American Journal of Tropical Medicine and Hygiene·Abdoulaye SeckYusuke Shimakawa
Nov 10, 2021·The Journal of Infectious Diseases·Alexander J StockdaleMelita A Gordon

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

Access
Excel

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.